FIELD: immunology.
SUBSTANCE: compositions with immunity-inducing activity against PDS5A protein in patients carrying HLA-A0201, as well as polypeptide with immunity-inducing activity against PDS5A protein in patients carrying HLA-A0201, are proposed.
EFFECT: this invention can find further application in the therapy of tumors expressing PDS5A protein.
8 cl, 8 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
ARTIFICIAL ANTIGEN-PRESENTING CELLS AND METHODS FOR THEIR APPLICATION | 2018 |
|
RU2763798C1 |
T-CELL RECEPTOR CONSTRUCTS AND THEIR USE | 2019 |
|
RU2785954C2 |
IMMUNO-INDUCING AGENT | 2016 |
|
RU2744843C2 |
NEUTRALIZATION OF LYMPHOCYTE INHIBITORY PATHWAYS | 2015 |
|
RU2734771C2 |
CANCER TREATMENT USING ANTI-NKG2A AGENTS | 2015 |
|
RU2721271C2 |
PEPTIDE DERIVED FROM FOXM1, AND INCLUDING ITS VACCINE | 2016 |
|
RU2738418C2 |
CHIMERIC ANTIGENIC (CAR) RECEPTOR AGAINST CD123 FOR USE IN TREATING MALIGNANT TUMORS | 2015 |
|
RU2724999C2 |
TREATMENT OF MALIGNANT NEOPLASM USING HUMANIZED CHIMERIC ANTIGEN RECEPTOR AGAINST BCMA | 2015 |
|
RU2751660C2 |
FUSION PROTEIN OF DCTN1 PROTEIN WITH RET PROTEIN | 2018 |
|
RU2813996C2 |
ANTIBODY AGAINST MALIGNANT CELL, ANTI-CANCER DRUG AND METHOD FOR TESTING MALIGNANT NEOPLASM | 2015 |
|
RU2753512C2 |
Authors
Dates
2021-10-26—Published
2016-08-05—Filed